secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001104659-22-117515
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences announces $750k offering with Series D preferred and warrant repricing
--------------------------------------------------------------------------------

- Gross proceeds $750k from sale of 2.39M shares, 2,500 Series D preferred, and pre-funded warrants at $0.26/share.
- Common warrants to purchase 2.88M shares at $0.30, exercisable after 6 months, expire 5.5 years.
- Existing warrants for 5.35M shares amended: exercise price cut to $0.30, non-exercisable for 6 months, extended expiry.
- Company to seek shareholder approval for reverse split and increase authorized shares from 100M to 300M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465922117515/0001104659-22-117515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465922117515/tm2230281d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-117515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer